Product Information
FENOFIBRATE 120 MG TABLET is a generic product labeled by Trifluent Pharma LLC, priced at $16.7550 per EA under NDC 73352010201. Its NADAC has been published 52 times since Oct 8, 2025.
FDA first approved this application on Sep 7, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
120 mg/1
Manufacturer
Trifluent Pharma LLCNDC
73352010201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA217732FDA Approved
9/7/2023
TE Code
AB
On Market Since
8/12/2025
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 120 MG TABLET has been published 52 times since Oct 8, 2025, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.7550 per EA |
|---|---|
| All-time high | $16.9540 (Sep 16, 2026) |
| All-time low | $15.7697 (Mar 18, 2026) |
| 52-week high | $16.9540 |
| 52-week low | $15.7697 |
| Median price | $16.2389 |
| Average price | $16.3155 |
| Largest weekly change | +3.0% (Nov 19, 2025) |
| Weeks tracked | 52 |
| Tracking since | Oct 8, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Trifluent Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fenofibrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 120 MG TABLET, manufactured by Trifluent Pharma LLC, is $16.7550 per EA (NDC 73352010201), effective Sep 30, 2026.
How has the price of FENOFIBRATE 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 120 MG TABLET has risen 5.6%. It has been tracked across 52 weekly CMS publications since Oct 8, 2025.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 120 MG TABLET?
Since Oct 8, 2025, the NADAC for FENOFIBRATE 120 MG TABLET has ranged from a low of $15.7697 (Mar 18, 2026) to a high of $16.9540 (Sep 16, 2026), with a median of $16.2389 per EA.
Are there cheaper alternatives to FENOFIBRATE 120 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 120 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 120 MG TABLET?
FENOFIBRATE 120 MG TABLET (NDC 73352010201) is labeled by Trifluent Pharma LLC, and CMS classifies it as a generic product.